Phenomenex, Inc., a global leader in the separation sciences business, announced today that it has acquired Bologna-based Chemtek Analytica S.R.L., a subsidiary of Labservice Analytica S.R.L., and privately-held SupWare, headquartered in Hilleroed, Denmark.
TORRANCE, Calif. (BusinessWire EON) April 11, 2007 --
Phenomenex, Inc., a global leader in the separation sciences business,
announced today that it has acquired Bologna-based Chemtek Analytica
S.R.L., a subsidiary of Labservice Analytica S.R.L., and privately-held
SupWare, headquartered in Hilleroed, Denmark.
Both companies were exclusive distributors for chromatography products
developed by Phenomenex. Terms of the acquisitions were not disclosed.
Phenomenex is a technology pioneer in research and manufacturing
chromatography products used in the separation, analysis and
purification of pharmaceuticals, biopharmaceuticals and a broad spectrum
of chemicals. With projected ’07 sales
exceeding $110 million and 465 employees, privately held Phenomenex has
offices in Canada, the U.K., Germany, Austria, France, Italy, Denmark,
Australia and New Zealand, and also sells its products through a network
of partners and distributors in 59 other countries.
“Phenomenex has had long, successful
partnerships with these companies, so buying them represents a natural
progression for us,” says Fasha Mahjoor,
founder and chief executive officer of Phenomenex. “They
understand our focus on constant innovation and unyielding drive to
maintain our position as the technology leader in chromatography. Both
share with us a commitment to stay close to the customer. As members of
the growing Phenomenex family, they will play an indispensable role in
building a cohesive, unifying, worldwide brand presence.”
Plans call for both companies to assume the Phenomenex corporate
identity. In Italy, the company will be called Phenomenex S.R.L. In
Denmark, the company will be known as Phenomenex ApS.
“Chemtek has collaborated closely with
Phenomenex for more than 20 years,” says
Alberto Albieri, newly-appointed sales and marketing manager with
Phenomenex S.R.L. and one of the founders and directors of Chemtek
Analytica.
“As Phenomenex has emerged as the technology
leader in chromatography consumables, we have worked hard doing our part
to contribute to its success in Italy. This is a perfect time for our
Italian customers, who range from pharmaceutical manufacturers to
environmental, petrochemical and healthcare companies, to have direct
access to all of the resources of Phenomenex.”
Similar sentiments were offered by Else Togo, general manager of
Phenomenex ApS.
“The pace of technology innovations in
chromatography products is astounding today,”
says Togo. “We have had a long partnership
with Phenomenex, and we know its commitment to new product development
is second to none. With important customers in life sciences, chemical,
biotech, and food and beverage, demand for Phenomenex’s
products in Denmark covers the spectrum of chromatography consumables.
Providing our customers with a direct pipeline will give us a strong
competitive edge.”
The transition process is expected to be brief and seamless. There will
be no layoffs or staff reductions. In fact, the teams of both
organizations will remain and each anticipates announcing staff
expansions sometime in the second quarter.
“Phenomenex has a reputation for leading its
peers each year with double digit financial gains, and these strategic
acquisitions position us favorably for future growth,”
says Bert G. Rietveld, director of business development for Phenomenex. “Being
responsive to the needs of our customers in the European Union is
critical to our success. That is why these acquisitions are investments
in our future.”
About Phenomenex, Inc.
Phenomenex, Inc., a global leader in separation sciences technology, is
a privately held corporation headquartered in Torrance, California.
Phenomenex is celebrating 25 years of innovation and achievement,
marking its birth as a company driven by a constant focus to innovate.
Phenomenex develops, manufactures and distributes chromatography
products for the separation, analysis and purification of
pharmaceuticals, biopharmaceuticals and a broad spectrum of chemicals.
It serves a broad base of customers worldwide involved in the life
sciences, environmental, chemical and healthcare industries. With
projected ’07 sales exceeding $110 million
and 465 employees, Phenomenex spans the globe with offices in Canada,
the U.K., Germany, Austria, France, Italy, Denmark, Australia and New
Zealand, and also sells its products through a network of partners and
distributors in 59 other countries.
For more information, visit www.phenomenex.com.
Trackback URL: http://www.prweb.com/pingpr.php/U3VtbS1aZXRhLVRoaXItQ3Jhcy1NYWduLVplcm8=
|
